APA (7th ed.) Citation

CC, L., WB, Y., CH, C., CL, W., JY, C., PY, C., . . . KY, C. (2024). CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity. Cell death & disease, 15(6), 434. https://doi.org/10.1038/s41419-024-06784-6

Chicago Style (17th ed.) Citation

CC, Liu, et al. "CXCR7 Activation Evokes the Anti-PD-L1 Antibody Against Glioblastoma by Remodeling CXCL12-mediated Immunity." Cell Death & Disease 15, no. 6 (2024): 434. https://doi.org/10.1038/s41419-024-06784-6.

MLA (9th ed.) Citation

CC, Liu, et al. "CXCR7 Activation Evokes the Anti-PD-L1 Antibody Against Glioblastoma by Remodeling CXCL12-mediated Immunity." Cell Death & Disease, vol. 15, no. 6, 2024, p. 434, https://doi.org/10.1038/s41419-024-06784-6.